EP2922828
4,6-DIAMINO-PYRIMIDINE DERIVATIVES AS BMI-1 INHIBITORS FOR TREATING CANCER
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
21.11.2013EP published:
8.7.2020EP application number:
13857326.6
EPO information:
European Patent Register
Max expiry date:
20.11.2033
Title:
4,6-DIAMINO-PYRIMIDINE DERIVATIVES AS BMI-1 INHIBITORS FOR TREATING CANCER
Timeline
Today
21.11.2013EP application
8.7.2020EP Publication
Owner
Name:
PTC Therapeutics, Inc.Address:
100 Corporate Court Middlesex Business Center, South Plainfield, New Jersey 07080, US
Inventor
Name:
LEE, Chang-SunAddress:
Belle Mead, NJ 08502, US
Name:
BAIAZITOV, RamilAddress:
East Brunswick, NJ 08816, US
Name:
CAO, LiangxianAddress:
Parlin, NJ 08859, US
Name:
DAVIS, Thomas, W.Address:
South Orange, NJ 07079, US
Name:
DU, WuAddress:
Cranbury, NJ 08512, US
Name:
LIU, RonggangAddress:
Berwyn, PA 19312, US
Name:
MOON, Young-choonAddress:
Belle Mead, NJ 08502, US
Name:
PAGET, Steven, D.Address:
Hillsborough, NJ 08844, US
Name:
REN, HongyuAddress:
Dayton, NJ 08810, US
Name:
SYDORENKO, NadiyaAddress:
Princeton, NJ 08540, US
Name:
WILDE, Richard, GeraldAddress:
Somerville, NJ 08876, US
Priority
Number:
201261728907 PDate:
21.11.2012Country:
US
Classification
Categories:
C07D 403/12, C07D 403/04, C07D 471/04, C07D 487/04, A61K 31/506, A61P 35/00